Drug Shortage Report for JAMP PIOGLITAZONE

Last updated on 2023-03-11 History
Report ID 137075
Drug Identification Number 02365529
Brand name JAMP PIOGLITAZONE
Common or Proper name Pioglitazone
Company Name JAMP PHARMA CORPORATION
Market Status DORMANT
Active Ingredient(s) PIOGLITAZONE
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 90
ATC code A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-07-31
Estimated end date 2023-08-31
Actual end date
Shortage status Actual shortage
Updated date 2023-03-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1310 RUE NOBEL
BOUCHERVILLE, QUEBEC
CANADA J4B 5H3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2021-04-07 English Compare
v2 2021-04-07 French Compare
v3 2022-12-09 English Compare
v4 2022-12-09 French Compare
v5 2023-02-03 English Compare
v6 2023-02-03 French Compare
v7 2023-03-11 English Compare
v8 2023-03-11 French Compare

Showing 1 to 8 of 8